Jan 16, 2019 (Heraldkeeper via COMTEX) — According to Coherent Market Insights, the global Enzyme Linked Immunosorbent Assay (ELISA) market was valued at US$ 1,583.4 million in 2017, and is projected to exhibit a CAGR of 5.1% during the forecast period (2017 – 2025). Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1505 Technological advancements in ELISA test kits are expected to foster growth of the global Enzyme Linked Immunosorbent Assay (ELISA) Market. Extensive research and development in the field of immunoassay and diagnostics is leading to increasing applications and novel approaches for incorporating ELISA in various medical fields. This has resulted in expansion of the range of ELISA products used in clinical and medical approaches. For instance, in November 2016, Inova Diagnostics received the U.S. Food and Drug Administration (FDA) approval for QUANTA Lite, a Calprotectin Extended range of quantitative ELISA assay that aids in the diagnosis of Inflammatory Bowel Disease (IBD) and helps to differentiate IBD from Irritable Bowel Syndrome (IBS). Similarly, in July 2015, Bio-Rad Laboratories, Inc. received th...